Roden R B, Greenstone H L, Kirnbauer R, Booy F P, Jessie J, Lowy D R, Schiller J T
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA.
J Virol. 1996 Sep;70(9):5875-83. doi: 10.1128/JVI.70.9.5875-5883.1996.
We report a system for generating infectious papillomaviruses in vitro that facilitates the analysis of papillomavirus assembly, infectivity, and serologic relatedness. Cultured hamster BPHE-1 cells harboring autonomously replicating bovine papillomavirus type 1 (BPV1) genomes were infected with recombinant Semliki Forest viruses that express the structural proteins of BPV1. When plated on C127 cells, extracts from cells expressing L1 and L2 together induced numerous transformed foci that could be specifically prevented by BPV neutralizing antibodies, demonstrating that BPV infection was responsible for the focal transformation. Extracts from BPHE-1 cells expressing L1 or L2 separately were not infectious. Although Semliki Forest virus-expressed L1 self-assembled into virus-like particles (VLPs), viral DNA was detected in particles only when L2 was coexpressed with L1, indicating that genome encapsidation requires L2. Expression of human papillomavirus type 16 (HPV16) L1 and L2 together in BPHE-1 cells also yielded infectious virus. These pseudotyped virions were neutralized by antiserum to HPV16 VLPs derived from European (114/K) or African (Z-1194) HPV16 variants but not by antisera to BPV VLPs, to a poorly assembling mutant HPV16 L1 protein, or to VLPs of closely related genital HPV types. Extracts from BPHE-1 cells coexpressing BPV L1 and HPV16 L2 or HPV16 L1 and BPV L2 were not infectious. We conclude that (i) mouse C127 cells express the cell surface receptor for HPV16 and are able to uncoat HPV16 capsids; (ii) if a papillomavirus DNA packaging signal exists, then it is conserved between the BPV and HPV16 genomes; (iii) functional L1-L2 interaction exhibits type specificity; and (iv) protection by HPV virus-like particle vaccines is likely to be type specific.
我们报道了一种在体外产生感染性乳头瘤病毒的系统,该系统有助于分析乳头瘤病毒的组装、感染性及血清学相关性。将携带自主复制的1型牛乳头瘤病毒(BPV1)基因组的培养仓鼠BPHE-1细胞用表达BPV1结构蛋白的重组Semliki森林病毒感染。当接种到C127细胞上时,同时表达L1和L2的细胞提取物诱导出大量转化灶,这些转化灶可被BPV中和抗体特异性阻止,表明BPV感染是导致灶性转化的原因。单独表达L1或L2的BPHE-1细胞提取物没有感染性。虽然Semliki森林病毒表达的L1能自组装成病毒样颗粒(VLP),但只有当L2与L1共表达时,颗粒中才能检测到病毒DNA,这表明基因组包装需要L2。在BPHE-1细胞中同时表达16型人乳头瘤病毒(HPV16)的L1和L2也产生了感染性病毒。这些假型病毒粒子被针对源自欧洲(114/K)或非洲(Z-1194)HPV16变体的HPV16 VLP的抗血清中和,但不被针对BPV VLP、组装不良的突变型HPV16 L1蛋白或密切相关的生殖道HPV型别的VLP的抗血清中和。共表达BPV L1和HPV16 L2或HPV16 L1和BPV L2的BPHE-1细胞提取物没有感染性。我们得出以下结论:(i)小鼠C127细胞表达HPV16的细胞表面受体,并且能够解开HPV16衣壳;(ii)如果乳头瘤病毒DNA包装信号存在,那么它在BPV和HPV16基因组之间是保守的;(iii)功能性L1-L2相互作用表现出型特异性;(iv)HPV病毒样颗粒疫苗的保护作用可能是型特异性的。